Na Luo
Shenzhen Maternity and Child Healthcare Hospital(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Immunotherapy and Immune Responses, RNA Interference and Gene Delivery, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer(2018)265 cited
- → Curcumin-Encapsulated Polymeric Micelles Suppress the Development of Colon Cancer In Vitro and In Vivo(2015)173 cited
- → Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer(2021)89 cited
- → Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2(2018)81 cited
- → TLR4 Promotes Breast Cancer Metastasis via Akt/GSK3β/β‐Catenin Pathway upon LPS Stimulation(2017)72 cited
- → The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells(2017)67 cited
- → Salubrinal protects against rotenone-induced SH-SY5Y cell death via ATF4-parkin pathway(2014)59 cited
- → Thermosensitive hydrogel containing dexamethasone micelles for preventing postsurgical adhesion in a repeated-injury model(2015)45 cited
- → TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways(2016)44 cited
- → PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review(2022)40 cited